M·CAM International
May 13, 2015
M·CAM is a research provider focused on intellectual property and intangible assets.

Celgene Revlimid® Validity Review

Celgene's $CELG patent families protecting their Revlimid® product do not appear to meet the criteria for legitimate patent protection.

Loading PDF

More from M·CAM International